Story not found
← Return to briefing
The Food and Drug Administration has approved a new drug to treat advanced pancreatic cancer. This breakthrough could potentially extend the survival of patients with metastatic pancreatic cancer. The approval was made on a Wednesday, marking a significant development for those affected by this condition.
Further details about the drug and its potential impact are available from the source, providing more information on this medical advancement.
This preview is provided by The Woodlands News. Full article available at .
Recent coverage curated from local and regional sources.
Dallas judge Ashley Wysocki on Tuesday extended an order preventing McKenna West from seeing or making medical decisions for a newborn she g…
A United Airlines passenger says a weather diversion on an Edinburgh, Scotland flight to Chicago led to a 20-hour travel nightmare through G…
In an all-encompassing interview, the new U.S Attorney for the Southern District of Texas said his office will follow the law when deciding …
NFL legend Tom Brady's new CardVault store in Palo Alto, California, was burglarized, just one week after opening.
The ultimate guide to 2026 eyewear: Find your perfect pair.
"This whole thing has spiraled." The MomTok chaos is in full view in the season 5 trailer for "The Secret Lives of Mormon Wives." The whole …
Pearland officials are proposing a balanced budget of nearly $137.8 million for fiscal year 2026-27.
When activated, property owners can enroll to receive an alert whenever a document is recorded under their registered name.
The Attorney General's office says 51-year-old Josh Kohut used his phone to record "upskirt" videos without the victim's knowledge.
The family of four has moved from California to the U.K. for an extended period of time.
The Woodlands Township would pay the city of Houston $50 million over the next three years to forestall the prospect of annexation.
Texas House Democrats are asking Gov. Greg Abbott to request the closing of a Texas immigration processing facility.
Free weekly digest. Local news that actually matters — no spam, no clickbait, easy unsubscribe.
By subscribing you agree to our privacy policy. We never sell your data.